Flora Peyvandi/ X
Aug 3, 2026, 11:59
Flora Peyvandi: Roctavian Withdrawal Signals Adoption Challenges
Flora Peyvandi, Professor of Internal Medicine at the University of Milan, shared a post on X about a recent article she and her colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis (RPTH), adding:
“Roctavian Withdrawal: exploring the gap between innovation and healthcare system readiness in haemophilia A gene therapy – Research and Practice in Thrombosis and Haemostasis.”
Title: Roctavian Withdrawal: exploring the gap between innovation and healthcare system readiness in haemophilia A gene therapy
Authors: Matteo Nicola Dario Di Minno, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause